Total Assets for Edwards Lifesciences (EW)
According to Edwards Lifesciences's latest reported financial statements, the company's latest reported total assets is $13.70B USD. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and net assets for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal AssetsSwitch metric
Latest period
$13.70B
YoY change
+4.9%
5Y CAGR
+13.6%
Peak year (2025)
$13.70B
Latest annual
$13.70B
Total Assets history chart for Edwards Lifesciences (EW) from 1999 to 2025
Total Assets history table for Edwards Lifesciences (EW) from 1999 to 2025
| Fiscal year | Period ended | Reported | Total Assets | YoY |
|---|---|---|---|---|
| 2025 | $13.70B | +4.9% | ||
| 2024 | $13.06B | +39.4% | ||
| 2023 | $9.36B | +12.9% | ||
| 2022 | $8.29B | -2.5% | ||
| 2021 | $8.50B | +17.5% | ||
| 2020 | $7.24B | +11.5% | ||
| 2019 | $6.49B | +21.9% | ||
| 2018 | $5.32B | -6.5% | ||
| 2017 | $5.70B | +26.3% | ||
| 2016 | $4.51B | +11.1% | ||
| 2015 | $4.06B | +15.2% | ||
| 2014 | $3.52B | +29.3% | ||
| 2013 | $2.72B | +22.7% | ||
| 2012 | $2.22B | +12.2% | ||
| 2011 | $1.98B | +12.1% | ||
| 2010 | $1.77B | +9.4% | ||
| 2009 | $1.62B | +15.4% | ||
| 2008 | $1.40B | +4.1% | ||
| 2007 | $1.35B | +7.9% | ||
| 2006 | $1.25B | +1.4% | ||
| 2005 | $1.23B | +10.5% | ||
| 2004 | $1.11B | +1.0% | ||
| 2003 | $1.10B | +9.2% | ||
| 2002 | $1.01B | +3.6% | ||
| 2001 | $973.00M | -10.6% | ||
| 2000 | $1.09B | -24.3% | ||
| 1999 | $1.44B | — |
Total Assets values are taken from Edwards Lifesciences's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Edwards Lifesciences (EW) reported total assets of $13.70B – edged up 4.9% year-over-year.
Through 2020–2025 (5 years), Edwards Lifesciences total assets delivered a +13.6% annualised rate; sustaining 3 straight years of year-over-year growth.
The highest annual total assets of $13.70B was reported in 2025. The lowest in the available history was $973.00M in 2001.
Edwards Lifesciences (EW) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $135.41B.
Edwards Lifesciences Total Assets by Year
Edwards Lifesciences Total Assets 2025: $13.70B
Edwards Lifesciences total assets in 2025 was $13.70B, edged up 4.9% from 2024. This figure represents the highest annual value in the available history.
Edwards Lifesciences Total Assets 2024: $13.06B
Edwards Lifesciences total assets in 2024 was $13.06B, surged 39.4% from 2023.
Edwards Lifesciences Total Assets 2023: $9.36B
Edwards Lifesciences total assets in 2023 was $9.36B, grew 12.9% from 2022.
Edwards Lifesciences Total Assets 2022: $8.29B
Edwards Lifesciences total assets in 2022 was $8.29B, edged down 2.5% below 2021.
Edwards Lifesciences Total Assets 2021: $8.50B
Edwards Lifesciences total assets in 2021 was $8.50B.
See more financial history for Edwards Lifesciences (EW).
Sector peers — Total Assets
Companies in the same sector as Edwards Lifesciences, ranked by their latest total assets.
| Company | Total Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $542.90B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $309.58B | Healthcare |
| Johnson & Johnson (JNJ) | $199.21B | Healthcare |
| Merck & Co., Inc. (MRK) | $136.87B | Healthcare |
| AbbVie Inc. (ABBV) | $133.96B | Healthcare |
| AstraZeneca PLC (AZN) | $114.07B | Healthcare |
| Eli Lilly and Company (LLY) | $112.48B | Healthcare |
| Amgen Inc. (AMGN) | $90.59B | Healthcare |
Frequently asked questions
What is Edwards Lifesciences's total assets?
- Latest reported total assets for Edwards Lifesciences (EW) is $13.70B (period ending December 31, 2025).
How has Edwards Lifesciences total assets changed year-over-year?
- Edwards Lifesciences (EW) total assets changed +4.9% year-over-year on the latest annual filing.
What is the long-term growth rate of Edwards Lifesciences total assets?
- Edwards Lifesciences (EW) total assets compound annual growth rate is +13.6% over the most recent 5 years available.
When did Edwards Lifesciences total assets hit its highest annual value?
- Edwards Lifesciences total assets reached its highest annual value of $13.70B in 2025.
What was Edwards Lifesciences total assets in 2024?
- Edwards Lifesciences (EW) total assets in 2024 was $13.06B.
What was Edwards Lifesciences total assets in 2025?
- Edwards Lifesciences (EW) total assets in 2025 was $13.70B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
EW Overview
Company profile, financial tools, and key metrics
EW Revenue Counter
Earns $199.88 every second. See per minute, hour, and day.
EW Earnings Counter
Earns $34.65 per second net profit. See per minute, hour, and day.
EW Economic Scale
Exceeds Fiji's GDP. Compare with world economies.
EW What If Invested
What if you had invested $1,000? See historical returns from any date.
EW How It Makes Money
Discover visual breakdown of $6.30B in revenue — where it comes from and where it goes.
EW Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
EW Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
EW Daily Price Character
Balanced · 50.0% historical win rate (green days). Streaks & record days.
EW Buybacks
0.93% TTM buyback yield. Shareholder yield & SBC comparison.
EW Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.